T.N. Yoganathan
Kinetek Pharmaceuticals Inc.
Vancouver
BC V6P6P2
Canada
Name/email consistency: high
- Integrin-linked kinase (ILK): a "hot" therapeutic target. Yoganathan, T.N., Costello, P., Chen, X., Jabali, M., Yan, J., Leung, D., Zhang, Z., Yee, A., Dedhar, S., Sanghera, J. Biochem. Pharmacol. (2000)









